AIM: Treatment response to five different @entity1534 eradication regimens were evaluated to see which is the best regimen in our setup. METHODS: @entity1 presenting with @entity1109 of acid peptic disease underwent @entity1729 and an antral CLO test. All those with a positive CLO test were included in the study. The study was carried out over a year and one trial was followed by another. The treatment regimens comprised of (1) @entity4546 20 mg once a day, colloidal @entity26586 120 mg three times a day, @entity868 200 mg three times a day (18 cases). (2) Colloidal bismuth subcitrate three times a day, @entity15183 100 mg three times a day, @entity868 200 mg three times a day (28 cases). (3) @entity4546 20 mg once a day, @entity4581 500 mg twice a day (21 cases). (4) @entity10042 30 mg once a day, @entity115 500 mg three times a day (21 cases). (5) @entity10042 once a day, @entity115 500 mg three times a day and @entity14698 150 mg twice a day (14 cases). Therapy for all 5 groups comprised of 14 days. Endoscopy and CLO test were done prior to the entry in the trial and at 28 days to see the response. RESULTS: Meta analysis was done for all the 5 regimens. For the purpose of analysis @entity1 were divided into 2 groups, i.e., those with peptic @entity1066 and positive CLO ( @entity10189 ( @entity10189 ) and those without peptic @entity1066 but positive CLO test (Non @entity1066 (NUD). @entity10189 was seen in 14 of 18 cases in group 1, 18 of 28 cases in group 2, 16 of 21 cases in group 3, 6 of 21 cases in group 4 and 3 of 14 cases in group 5. In @entity10189 after 14 days of therapy, lesions healed and CLO became negative in 50% cases each in group 1 and 2, 56% in group 3, 83% in group 4 and all in group 5, while in NUD, 25%, 60%, 80%, 47% and 82% respectively showed @entity1534 eradication. CONCLUSION: Of the different therapies one proton pump inhibitor with two antibiotics gave best results in @entity1066 and @entity1534 eradication in @entity1066 and non @entity1066 .

Comparison of five different treatment regimens for XXXX eradication.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity15183 :: ('MESH:D005664', 'Chemical') :: ['furazolidone'] @entity10189 :: ('MESH:D010437', 'Disease') :: ['peptic ulcer disease', 'PUD'] @entity868 :: ('MESH:D008795', 'Chemical') :: ['metronidazole', 'Metronidazole'] @entity115 :: ('MESH:D000658', 'Chemical') :: ['Amoxycillin'] @entity4581 :: ('MESH:D017291', 'Chemical') :: ['Clarithromycin'] @entity1109 :: ('MESH:D012678', 'Disease') :: ['upper GI symptoms'] @entity1066 :: ('MESH:D014456', 'Disease') :: ['ulcer', 'ulcer dyspepsia', 'ulcer healing'] @entity26586 :: ('MESH:C002791', 'Chemical') :: ['bismuth subcitrate'] @entity10042 :: ('MESH:C058687', 'Chemical') :: ['Lansoprazole'] @entity1729 :: ('MESH:D012141', 'Disease') :: ['upper GI endoscopy'] @entity1534 :: ('210', 'Species') :: ['H. pylori', 'H. Pylori'] @entity14698 :: ('MESH:D015575', 'Chemical') :: ['Roxithromycin'] @entity4546 :: ('MESH:D009853', 'Chemical') :: ['Omeprazole']
@entity1534 :: (210,Species) :: ['H. pylori']
